GSK plc ups stake in Indian arm GlaxoSmithKline Consumer Healthcare for Rs 4,800 cr
- Army used 'chilly grenades' to catch Pakistani militant Sajjad Ahmed
- IPL Governing Council proposes two new teams to replace CSK, RR
- Central govt announces 98 Smart Cities, Naidu terms them 'safe investments for pvt firms'
- Sheena Bora murder: Police meet Mikhail Bora; five-day transit remand for Sanjeev Khanna
- ISRO launches rocket carrying GSAT-6 from Sriharikota
Drug major GlaxoSmithKline Plc (GSK) has increased stake in its Indian subsidiary GlaxoSmithKline Consumer Healthcare Ltd to 72.5 per cent in a transaction worth Rs 4,800 crore.
In a statement, GSK said pursuant to the voluntary open offer undertaken by its subsidiary, GlaxoSmithKline Pte Ltd, it has increased its stake in GlaxoSmithKline Consumer Healthcare Ltd, its publicly-listed consumer healthcare subsidiary in India, from 43.2 per cent to 72.5 per cent.
"We are very pleased with the outcome of this transaction, which will further increase our exposure to a key emerging market," GSK Chief Strategy Officer David Redfern said.
He further added that "It is a significant vote of confidence in the long-term growth prospects of our consumer healthcare business in India."
During the offer period, which commenced on January 17, 2013 and closed on January 30, 2013, shareholders of GlaxoSmithKline Consumer Healthcare Ltd validly tendered about 1.23 crore shares representing 29.3 per cent of the total shares outstanding, the company said.
The offer of Rs 3,900 per share values the transaction at around Rs 4,800 crore, it added.
"The final payment for shares tendered and accepted will be completed on or before February 13, at which point GlaxoSmithKline Pte Ltd would acquire full beneficial ownership of the shares tendered in the open offer," it said.